|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
2880
|
FTRU
|
2880.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for 5-[131I]Iodo- and 5-[211At]Astato 1-(2-deoxy-2-fluoro-β-D-ribofuranosyl)uracil
Precursor for [76Br]Bromo-2′-fluoro-2′-deoxyuridine
|
|
|
|
|
|
|
|
|
Molar Mass: 409.00
|
|
|
C12H19FN2O5Sn
|
|
|
[336881-26-6]
|
|
|
|
|
|
Colourless crystals packaged in dark glass screw cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H, 19F, and 119Sn NMR specta
|
|
|
Chemical Name:
CA index name: 2,4(1H,3H)-Pyrimidinedione, 1(2-deoxy-2-fluoro-β-D-ribofuranosyl)-5-(trimethylstannyl)-
|
|
|
Synonymes:
2′-Deoxy-2′-fluoro-5-(trimethylstannyl)-uridine ; FTAU-epimer
|
|
|
Literature:
1. Vaidyanathan G. et al. Preparation of 5-[131]Iodo- and 5-[211At]Astato-1-(2-Deoxy-2-Fluoro-beta-D-Arabinofuranosyl)Uracil by a Halodestannylation Reaction. Nucl. Med. Biol. 1998, 25, 487-496.
|
|
|
2. Lu L. et al. Synthesis of [76Br]Bromfluorodeoxyuridine and Its Validation with Regard to Uptake, DNA Incorporation, and Excretion Modulation in rats. J. Nucl. Med. 2000, 41, 1746-1752.
|
|
|
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|